Annual report [Section 13 and 15(d), not S-K Item 405]

Condensed Consolidated Statements of Stockholders' Equity

v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Class A and Class B Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2023   263,741,000        
Beginning balance (in shares) at Jan. 31, 2023       14,131,000    
Beginning balance at Jan. 31, 2023 $ 549,332 $ 9 $ 1,074,149 $ (23,831) $ (4,384) $ (496,611)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation - equity classified awards 57,230   57,230      
Exercise of stock options and release of vested restricted stock units (in shares)   10,948,000        
Exercise of stock options and release of vested restricted stock units 43,333   43,333      
Issuance of common shares upon ESPP purchases (in shares)   976,000        
Issuance of common shares upon ESPP purchases 7,437   7,437      
Common stock repurchased, including accrued excise tax (in shares)   (2,400,000)        
Common stock repurchased, including accrued excise tax (29,579)         (29,579)
Other adjustment 0 $ (1) 1      
Other comprehensive (loss) income 548       548  
Net income 51,403         51,403
Ending balance (in shares) at Jan. 31, 2024   273,265,000        
Ending balance (in shares) at Jan. 31, 2024       14,131,000    
Ending balance at Jan. 31, 2024 679,704 $ 8 1,182,150 $ (23,831) (3,836) (474,787)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation - equity classified awards 61,055   61,055      
Exercise of stock options and release of vested restricted stock units (in shares)   6,862,000        
Exercise of stock options and release of vested restricted stock units 19,908   19,908      
Issuance of common shares upon ESPP purchases (in shares)   776,000        
Issuance of common shares upon ESPP purchases 5,807   5,807      
Common stock repurchased, including accrued excise tax (in shares)   (25,460,000)        
Common stock repurchased, including accrued excise tax (272,887)         (272,887)
Other comprehensive (loss) income (3,133)       (3,133)  
Net income $ 121,609         121,609
Ending balance (in shares) at Jan. 31, 2025   255,443,000        
Ending balance (in shares) at Jan. 31, 2025 14,130,784     14,131,000    
Ending balance at Jan. 31, 2025 $ 612,063 $ 8 1,268,920 $ (23,831) (6,969) (626,065)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation - equity classified awards 87,151   87,151      
Exercise of stock options and release of vested restricted stock units (in shares)   10,128,000        
Exercise of stock options and release of vested restricted stock units 15,289   15,289      
Issuance of common shares upon ESPP purchases (in shares)   770,000        
Issuance of common shares upon ESPP purchases 5,127   5,127      
Common stock repurchased, including accrued excise tax (in shares)   (17,617,000)        
Common stock repurchased, including accrued excise tax (151,150) $ (1)       (151,149)
Other comprehensive (loss) income 1,258       1,258  
Net income $ 22,905         22,905
Ending balance (in shares) at Jan. 31, 2026   248,724,000        
Ending balance (in shares) at Jan. 31, 2026 14,130,784     14,131,000    
Ending balance at Jan. 31, 2026 $ 592,643 $ 7 $ 1,376,487 $ (23,831) $ (5,711) $ (754,309)